Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. US Stem Cell Clinic, LLC
WARNING LETTER
•US Stem Cell Clinic, LLC•May 11, 2017

US Stem Cell Clinic, LLC – FDA Warning Letter, May 11, 2017

Record Details

The FDA issued a Warning Letter to US Stem Cell Clinic, LLC (USSC) following an inspection from April 10 to May 11, 2017. The inspection revealed that USSC recovers and processes adipose tissue into stromal vascular fraction (SVF) for autologous use, administered intravenously or intrathecally, to treat various conditions including Parkinson's, ALS, and heart disease. The FDA determined that USSC's SVF product is an unapproved drug and biological product under the FD&C Act and PHS Act, as it does not meet the minimal manipulation or homologous use criteria for regulation solely as an HCT/P.

The letter cited significant deviations from current Good Manufacturing Practice (CGMP) and Good Tissue Practice (CGTP), many of which were similar to observations from a previous 2015 inspection. Key violations included: failure to validate aseptic processes and prevent microbiological contamination (e.g., lack of validation, dust accumulation, improper disinfectants), failure to validate the manufacturing process, inadequate laboratory testing (e.g., sterility and endotoxin testing), insufficient environmental monitoring, lack of written procedures for equipment cleaning/maintenance, inadequate equipment records, improper personnel gowning (non-sterile masks/caps), lack of final product testing specifications, failure to establish acceptance criteria and procedures for components, use of unreleased components (e.g., "research use only" reagents), absence of a quality control unit, incomplete batch production

Company
US Stem Cell Clinic, LLC
Inspection date
May 11, 2017
Product type
Biologics
Office
Florida District Office
People
  • Elizabeth A. Waltrip (Program Division Director)
  • Randall L. Morris (Compliance Officer)
View Company Profile

ID · 22bea09c-22d6-4c25-8706-fe26cd4c4393

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 351(a)(2)(B)42 U.S.C. 262(i)21 CFR 1271.3(d)21 CFR 1271.10(a)21 CFR 1271.3(f)(1)21 CFR 1271.3(c)21.U.S.C. 355(a)42 U.S.C. 262(a)21 U.S.C. 355(i)

Full citation text and observation details available on the Dashboard.

Other documents for US Stem Cell Clinic, LLC
  • 483 - 2017-05-11May 11, 2017
  • 483 - 2015-12-07December 7, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore US Stem Cell Clinic, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.